Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & EquivalentsCommon EquityCurrent AssetsLiabilities and Shareholders EquityNon-Current AssetsOperating LeasesOther Non-Current AssetsPayablesPrepaid AssetsRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Spruce Biosciences (SPRB) Short term Debt (2022 - 2025)

Spruce Biosciences (SPRB) has disclosed Short term Debt for 4 consecutive years, with $539000.0 as the latest value for Q3 2025.

  • Quarterly Short term Debt fell 66.77% to $539000.0 in Q3 2025 from the year-ago period, while the trailing twelve-month figure was $539000.0 through Sep 2025, down 66.77% year-over-year, with the annual reading at $1.6 million for FY2024, 0.0% changed from the prior year.
  • Short term Debt for Q3 2025 was $539000.0 at Spruce Biosciences, down from $943000.0 in the prior quarter.
  • The five-year high for Short term Debt was $1.6 million in Q4 2022, with the low at $405000.0 in Q1 2022.
  • Average Short term Debt over 4 years is $1.3 million, with a median of $1.6 million recorded in 2022.
  • The sharpest move saw Short term Debt surged 300.49% in 2023, then tumbled 66.77% in 2025.
  • Over 4 years, Short term Debt stood at $1.6 million in 2022, then changed by 0.0% to $1.6 million in 2023, then changed by 0.0% to $1.6 million in 2024, then crashed by 66.77% to $539000.0 in 2025.
  • According to Business Quant data, Short term Debt over the past three periods came in at $539000.0, $943000.0, and $1.3 million for Q3 2025, Q2 2025, and Q1 2025 respectively.